Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation
Titel:
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation
Auteur:
Beers, Stephen A. Chan, Claude H.T. James, Sonya French, Ruth R. Attfield, Kathrine E. Brennan, Claire M. Ahuja, Anupama Shlomchik, Mark J. Cragg, Mark S. Glennie, Martin J.